CD79B Proteïne (C-His, Human)

CD79B

AGM6, B29, Ig-beta, IGB, Igbeta

C-His

< 1.0 EU per μg protein as determined by the LAL method.

≥ 95 % as determined by SDS-PAGE. ≥ 95 % as determined by SEC-HPLC.

1.Loaded Anti-CD79B (Research Grade Polatuzumab biosimilar) on ProA Biosensor, can bind Recombinant Human CD79B Protein, His Tag (Cat. No. 29750-H08H) with an affinity constant of 12.9 nM as determined in BLI assay (Sartorius Octet RED384) (Routinely tested) . 2.Immobilized Recombinant Human CD79B Protein (ECD, His Tag), HPLC-verified (Cat: 29750-H08H) at 1 μg/mL (100 μL/well) can bind Anti-CD79B (Research Grade Polatuzu*mab Biosimilar), the EC50 is 1.1 ng/mL (Routinely tested) . 3.Immobilized Recombinant Human CD79B Protein (ECD, His Tag), HPLC-verified (Cat: 29750-H08H) at 1 μg/mL (100 μL/well) can bind Anti-CD79B (Research Grade Polatuzu*mab Biosimilar), the EC50 is 1.1 ng/mL (Routinely tested) .

Met1-Asp159

The recombinant human CD79B consists of 142 amino acids and predicts a molecular mass of 16.7 kDa. As a result of glycosylation, it migrates as an approximately 32.1 KDa band in SDS-PAGE under reducing conditions.

Human